Sign up
Quantellect · Congress · Trade Detail
NASDAQ: REGNRegeneron Pharmaceuticals Inc
DemocratHouse

Josh Gottheimer bought Regeneron Pharmaceuticals Inc (NASDAQ: REGN)

Josh Gottheimer (D-NJ), a U.S. Representative, has disclosed 21 trades in Regeneron Pharmaceuticals Inc (REGN) since 2019, 8 purchases and 13 sales, worth an estimated $168K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Josh Gottheimer bought $1,001 - $15,000 of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) on May 27, 2020. Since that trade, REGN is up +36.84% against the S&P 500 up +165.83%, an outperformance of -128.99%.

Across these filings, Josh Gottheimer has been a net seller of REGN (a buy-to-sell ratio of 0.62). The most recent disclosed REGN transaction shown was dated January 24, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

REGN trades
21
Disclosed Vol
$168K
Buys
8
38%
Sells
13
62%
Buy / Sell
0.62
ratio
First → Last
2019–2025

Josh Gottheimer's REGN trades vs the price

REGN is up +36.84% since Josh Gottheimer bought on May 27, 2020, versus +165.83% for the S&P 500.

Performance since this trade

Price change since trade
+36.84%
S&P 500 change since trade
+165.83%
Outperformance vs S&P 500
-128.99%

All Josh Gottheimer REGN trades

TradedTypeSizeReturnEst. profit
January 24, 2025SELL$670.25+10.16%
November 29, 2024SELL$744.07-0.77%
November 19, 2024SELL$738.50-0.02%
October 23, 2024SELL$933.68-20.92%
July 1, 2024SELL$1048.36-29.57%
February 8, 2024SELL$938.68-21.34%
November 13, 2023SELL$790.17-6.56%
August 21, 2023BUY$837.45-11.84%-$1K
July 11, 2023BUY$710.96+3.85%-$239
June 22, 2023SELL$773.42-4.54%

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Josh Gottheimer & REGN trading FAQ

Is it legal for Josh Gottheimer to trade Regeneron Pharmaceuticals Inc (REGN) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Regeneron Pharmaceuticals Inc (REGN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Josh Gottheimer buy REGN?

Josh Gottheimer disclosed a purchase of $1,001 - $15,000 of Regeneron Pharmaceuticals Inc (REGN) on May 27, 2020, according to public STOCK Act filings.

How has REGN performed since Josh Gottheimer's trade?

Since Josh Gottheimer bought REGN on May 27, 2020, the stock is up +36.84%, versus +165.83% for the S&P 500 over the same period, an outperformance of -128.99%.

How many times has Josh Gottheimer traded REGN?

Josh Gottheimer has disclosed 21 REGN trades since 2019 (8 purchases and 13 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional REGN trades?

Quantellect tracks every disclosed congressional trade in Regeneron Pharmaceuticals Inc (REGN) on the Regeneron Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.

Josh Gottheimer's REGN tradesAll congressional filings for Regeneron Pharmaceuticals IncJosh Gottheimer's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.